Literature DB >> 21754254

Bis[(1-methyl-1H-tetra-zol-5-yl)sulfan-yl]methane.

Wei Wei1, Zheng-Qiang Xia, San-Ping Chen, Sheng-Li Gao.   

Abstract

The mol-ecule of the title compound, C(5)H(8)N(8)S(2), lies on a twofold rotation axis that relates on 1-methyl-tetra-zolyl group to the other; the five-membered rings are twisted by 53.1 (1)°.

Entities:  

Year:  2011        PMID: 21754254      PMCID: PMC3100044          DOI: 10.1107/S1600536811011007

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the synthesis and pharmacological activity of compounds containing tetra­zole groups, see: Semenov (2002 ▶); Upadhayaya et al. (2004 ▶). For a related structure, see: Bronisz (2002 ▶).

Experimental

Crystal data

C5H8N8S2 M = 244.31 Orthorhombic, a = 6.415 (3) Å b = 7.314 (3) Å c = 22.204 (8) Å V = 1041.9 (7) Å3 Z = 4 Mo Kα radiation μ = 0.49 mm−1 T = 296 K 0.15 × 0.12 × 0.08 mm

Data collection

CBruker SMART area-detector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2002 ▶) T min = 0.930, T max = 0.962 4692 measured reflections 936 independent reflections 482 reflections with I > 2σ(I) R int = 0.118

Refinement

R[F 2 > 2σ(F 2)] = 0.063 wR(F 2) = 0.108 S = 1.21 936 reflections 70 parameters H-atom parameters constrained Δρmax = 0.34 e Å−3 Δρmin = −0.38 e Å−3 Data collection: SMART (Bruker, 2002 ▶); cell refinement: SAINT (Bruker, 2002 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXL97. Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536811011007/ng5140sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536811011007/ng5140Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C5H8N8S2F(000) = 504
Mr = 244.31Dx = 1.558 Mg m3Dm = 1.558 Mg m3Dm measured by not measured
Orthorhombic, PbcnMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2n 2abCell parameters from 214 reflections
a = 6.415 (3) Åθ = 2.5–18.9°
b = 7.314 (3) ŵ = 0.49 mm1
c = 22.204 (8) ÅT = 296 K
V = 1041.9 (7) Å3Flake-like, colourless
Z = 40.15 × 0.12 × 0.08 mm
CBruker SMART area-detector diffractometer936 independent reflections
Radiation source: fine-focus sealed tube482 reflections with I > 2σ(I)
graphiteRint = 0.118
φ and ω scansθmax = 25.1°, θmin = 1.8°
Absorption correction: multi-scan (SADABS; Bruker, 2002)h = −7→7
Tmin = 0.930, Tmax = 0.962k = −8→4
4692 measured reflectionsl = −25→26
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.063Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.108H-atom parameters constrained
S = 1.21w = 1/[σ2(Fo2) + (0.P)2 + 0.7202P] where P = (Fo2 + 2Fc2)/3
936 reflections(Δ/σ)max < 0.001
70 parametersΔρmax = 0.34 e Å3
0 restraintsΔρmin = −0.38 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/UeqOcc. (<1)
S11.1330 (2)1.03366 (18)0.19301 (6)0.0521 (4)
N30.6134 (7)0.9428 (6)0.1121 (2)0.0590 (13)
C20.9188 (8)0.9782 (6)0.1491 (2)0.0391 (13)
N40.7207 (7)1.0077 (6)0.16107 (17)0.0498 (12)
N10.9358 (7)0.8966 (6)0.09509 (17)0.0463 (11)
C11.1179 (8)0.8355 (7)0.0621 (2)0.0617 (16)
H1A1.16920.93360.03750.093*
H1B1.08080.73380.03690.093*
H1C1.22420.79850.08990.093*
N20.7401 (8)0.8743 (6)0.07305 (18)0.0561 (13)
C31.00001.1654 (9)0.25000.050 (2)
H3A1.10111.24390.26970.074*0.50
H3B0.89891.24390.23030.074*0.50
U11U22U33U12U13U23
S10.0481 (9)0.0665 (10)0.0418 (8)0.0008 (8)−0.0041 (7)−0.0064 (7)
N30.049 (3)0.061 (3)0.068 (3)−0.006 (3)−0.010 (3)0.001 (3)
C20.050 (4)0.034 (3)0.033 (3)−0.004 (3)−0.002 (2)0.004 (2)
N40.041 (3)0.061 (3)0.047 (3)0.002 (2)0.004 (2)0.004 (2)
N10.051 (3)0.053 (3)0.035 (2)−0.004 (2)−0.003 (2)−0.003 (2)
C10.062 (4)0.075 (4)0.049 (3)0.001 (3)0.004 (3)−0.012 (3)
N20.051 (3)0.068 (3)0.050 (3)−0.004 (3)−0.008 (3)0.000 (2)
C30.061 (6)0.054 (5)0.034 (4)0.000−0.012 (4)0.000
S1—C21.734 (5)N1—C11.450 (6)
S1—C31.805 (4)C1—H1A0.9600
N3—N21.289 (5)C1—H1B0.9600
N3—N41.372 (5)C1—H1C0.9600
C2—N41.316 (6)C3—S1i1.805 (4)
C2—N11.343 (5)C3—H3A0.9700
N1—N21.357 (5)C3—H3B0.9700
C2—S1—C398.31 (19)H1A—C1—H1B109.5
N2—N3—N4110.6 (4)N1—C1—H1C109.5
N4—C2—N1109.4 (4)H1A—C1—H1C109.5
N4—C2—S1127.8 (4)H1B—C1—H1C109.5
N1—C2—S1122.8 (4)N3—N2—N1107.1 (4)
C2—N4—N3105.5 (4)S1i—C3—S1115.5 (4)
C2—N1—N2107.5 (4)S1i—C3—H3A108.4
C2—N1—C1130.8 (5)S1—C3—H3A108.4
N2—N1—C1121.7 (4)S1i—C3—H3B108.4
N1—C1—H1A109.5S1—C3—H3B108.4
N1—C1—H1B109.5H3A—C3—H3B107.5
  2 in total

1.  Synthesis of novel substituted tetrazoles having antifungal activity.

Authors:  Ram Shankar Upadhayaya; Sanjay Jain; Neelima Sinha; Nawal Kishore; Ramesh Chandra; Sudershan K Arora
Journal:  Eur J Med Chem       Date:  2004-07       Impact factor: 6.514

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

  2 in total
  2 in total

1.  Bis[(1-methyl-1H-tetra-zol-5-yl)sulfan-yl]ethane.

Authors:  Chun-Rong Li; Tao Chen; Zheng-Qiang Xia
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-18

2.  5,5'-[(1,4-Phenyl-enedimethyl-ene)bis-(sulfanedi-yl)]bis-(1-methyl-1H-1,2,3,4-tetra-zole).

Authors:  Dan-Feng He; Jin-Jun Deng; Fu-Jiang Zhou; Hong-Sheng Liu; Li-Min Wang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.